Press Room

2016

Keynote Speaker Announced for 12th Annual Cardiometabolic Health Congress

Boston, December 1, 2016 – The Cardiometabolic Health Congress has announced Stanley Hazen, MD, PhD, Head of the Section for Preventive Cardiology and Rehabilitation of the Cleveland Clinic as its Keynote speaker for the 12th Annual CMHC, taking place October 4-7, 2017, at the Sheraton in Boston, MA.


FOR IMMEDIATE RELEASE

Contact: Christie Garcia
Tel.: 877-571-4700
E-mail: info@cardiometabolichealth.org

Boston, December 1, 2016 – The Cardiometabolic Health Congress has announced Stanley Hazen, MD, PhD, Head of the Section for Preventive Cardiology and Rehabilitation of the Cleveland Clinic as its Keynote speaker for the 12th Annual CMHC, taking place October 4-7, 2017, at the Sheraton in Boston, MA. Specializing in preventive cardiovascular care, including the treatment of hyperlipidemia, diabetes, hypertension, and obesity, Dr. Hazen will discuss his groundbreaking work concerning gut microbes as a factor and therapeutic target in cardiometabolic diseases. Dr. Hazen has received numerous awards including election to membership in honorary societies in science and clinical arenas alike and also serves as reviewer and/or is on the editorial board for many scientific journals, including Circulation and the Journal of Lipid Research.

The 3 ½-day CMHC has become the largest US-based, multidisciplinary conference focused solely on the prevention, diagnosis, and management of cardiovascular and metabolic diseases. The 12th Annual CMHC will kick off on Wednesday, October 4 with a Pre-conference “Business of Medicine” Day with the remaining days focused on dyslipidemia, atherosclerosis, and cardiovascular risk reduction; lifestyle management of cardiovascular disease; diabetes management; and hypertension, cardio-renal syndrome, and heart failure.

The Cardiometabolic Health Congress will also host the 2017 CMHC Regional Conference Series: Focus on Frontline Education. The 1-day, primary-care centered meetings will provide updates on current, new, and emerging therapies, treatment guidelines, and practical strategies to personalize care and empower patients to reduce global cardiometabolic risk and improve clinical outcomes. The Series will take place in Atlanta, Georgia on March 25; San Diego, California on May 6; and in Chicago, Illinois on August 12.

Early-bird pricing on the Regional Conference Series and the 12th Annual CMHC is available through December 31, 2016. For more information and registration details visit: http://www.cardiometabolichealth.org/2017/schedule.html or call 877-571-4700.

New Features, Additional Keynote Speakers Will Round Out 11th Annual Cardiometabolic Health Congress

Boston, September 27, 2016 – Continuing its dedication to translating late-breaking clinical research on cardiometabolic risk reduction into practical and targeted education, the Cardiometabolic Health Congress will hold its 11th Annual CMHC from October 5-8, 2016 at the Sheraton in Boston, MA.


FOR IMMEDIATE RELEASE

Contact: Christie Garcia
Tel.: 877-571-4700
E-mail: info@cardiometabolichealth.org

Boston, September 27, 2016 – Continuing its dedication to translating late-breaking clinical research on cardiometabolic risk reduction into practical and targeted education, the Cardiometabolic Health Congress will hold its 11th Annual CMHC from October 5-8, 2016 at the Sheraton in Boston, MA.

New features of the CMHC this year include two Practice Management workshops (“Capital – What Healthcare Professionals Need to Know About Money” and “Leadership and Management for Healthcare Professionals”) and a symposium on nutritional interventions in clinical practice, all taking place on Wednesday, October 5.

There will be a total of 5 keynotes during this year’s CMHC. The General Sessions, which also begin on Wednesday, October 5, will kick off with a keynote by Dr. Steven Nissen titled “Intravascular Ultrasound Insights into the Regression and Progression of Coronary Atherosclerosis.” Other keynotes will be presented by Dr. Peter Libby, speaking on the increasing prevalence of triglycerides as a cardiovascular risk factor; Dr. Suzanne Oparil presenting an update and clinical implications of the SPRINT trial; Dr. C. Ronald Kahn discussing the gut microbiome as a modifier of insulin resistance and metabolic syndrome; and Dr. Subodh Verma lending his insight on obesity fat distribution and cardiovascular risk.

Featured sessions on Thursday, October 6 include “Late-Breaking Clinical Trials and FDA Update,” moderated by Christie M. Ballantyne, MD and joined by Deepak L. Bhatt, MD, Robert H. Eckel, MD, Keith C. Ferdinand, MD, and Jay S. Skyler, MD. Dr. Bhatt will also moderate the debate, “The Latest in Antithrombotic Therapy: The Experts Take Sides,” with Kenneth Mahaffey, MD and Gregg W. Stone, MD during the session on Dyslipidemia, Atherosclerosis and Cardiovascular Disease Risk Reduction.

Dr. Clyde Yancy will discuss heart failure in the context of SPRINT during the Hypertension, Cardio-Renal, and Heart Failure session on Friday, October 7 and Dr. George Bakris will offer perspective on SGLT-2 inhibitors as second-line therapy. The Diabetes session taking place later that day will feature presentations on the results of CV outcomes trials and diabetes therapies, the implications of recent trials on the management of diabetes, and future directions of insulin and non-insulin therapies.

Coming to a conclusion on Saturday, October 8 with a session focusing on Obesity, Lifestyle Management, and Cardiovascular Disease, highlights will include Drs. Lee Kaplan and Francesco Rubino presenting the newest evidence on metabolic surgery and Dr. Caroline Apovian discussing the latest information on obesity treatments and pharmacology guidelines for clinicians.

“This conference has it all, from emerging research to the latest clinical guidelines to putting that knowledge into everyday practice,” Atul Soreng, MD, has said.

For a complete list of speakers, agenda, and registration details for the 11th Annual Cardiometabolic Health Congress visit: http://www.cardiometabolichealth.org/2016/index.html or call 877-571-4700.

General Session Highlights Announced for 11th Annual Cardiometabolic Health Congress

Boston, August 17, 2016 – The Cardiometabolic Health Congress has announced General Session Highlights for the 11th Annual CMHC, taking place October 5-8, 2016, at the Sheraton in Boston, MA. Each year, the CMHC provides a one-of-a-kind opportunity for healthcare professionals to stay informed on the latest scientific and clinical developments in the overlapping disease areas of cardiovascular and metabolic disease through a comprehensive and integrated agenda.


FOR IMMEDIATE RELEASE

Contact: Christie Garcia
Tel.: 877-571-4700
E-mail: info@cardiometabolichealth.org

Boston, August 17, 2016 – The Cardiometabolic Health Congress has announced General Session Highlights for the 11th Annual CMHC, taking place October 5-8, 2016, at the Sheraton in Boston, MA. Each year, the CMHC provides a one-of-a-kind opportunity for healthcare professionals to stay informed on the latest scientific and clinical developments in the overlapping disease areas of cardiovascular and metabolic disease through a comprehensive and integrated agenda.

Session I, taking place on Thursday, October 6, focuses on Dyslipidemia, Atherosclerosis and Cardiovascular Disease, and includes presentations and discussion on late-breaking clinical trials and updates from the FDA; a Keynote presentation by Dr. Peter Libby on the increasing prevalence of cardiovascular risk factors, specifically, triglycerides; and the latest in lipid-modifying and antithrombotic therapies.

On Friday, October 7, Hypertension, Cardio-Renal, and Heart Failure comprise Session II, with the recent SPRINT trial, the results of which left clinicians with many unanswered questions, providing the basis for many of the presentations. Session II will include a Keynote from Dr. Suzanne Oparil, one of SPRINT’s principal investigators; patient case discussions; a presentation by Dr. Clyde Yancy on heart failure in the context of SPRINT; and an examination of SGLT2 inhibitors as second-line therapy. Later that day, Diabetes Management takes the stage in Session III. Keynote speaker Dr. C. Ronald Kahn will discuss the gut microbiome as a modifier of insulin resistance and metabolic syndrome; results of CV outcomes trials and diabetes therapies, the implications of recent trials on the management of diabetes, and future directions of insulin and non-insulin therapies alike will be discussed.

The 11th Annual CMHC will conclude Saturday, October 8 with Session IV, which will cover Obesity, Lifestyle Management, and Cardiovascular Disease. Dr. Subodh Verma will present a Keynote on obesity fat distribution and cardiovascular risk; Drs. Lee Kaplan and Francesco Rubino will discuss the newest evidence on metabolic surgery; and Dr. Caroline Apovian will present the latest on obesity treatments and pharmacology guidelines for clinicians.

For a complete list of speakers, agenda, and registration details for the 11th Annual Cardiometabolic Health Congress visit: http://www.cardiometabolichealth.org/2016/index.html or call 877-571-4700.

Cardiometabolic Health Congress Holds Successful Primary-Care Focused Best of the CMHC Regional Conference Series

Chicago, June 21, 2016 – Built on the reputation and first-rate education offered at the annual CMHC in Boston, more than 100 primary care physicians and healthcare professionals attended the second Best of the CMHC series this past Saturday, June 18, 2016 in Chicago, IL. Consisting of live, focused, interactive educational sessions in a convenient 1-day format the conference provided: Read More


FOR IMMEDIATE RELEASE

Contact: Christie Garcia
Tel.: 877-571-4700
E-mail: info@cardiometabolichealth.org

Chicago, June 21, 2016 – Built on the reputation and first-rate education offered at the annual CMHC in Boston, more than 100 primary care physicians and healthcare professionals attended the second Best of the CMHC series this past Saturday, June 18, 2016 in Chicago, IL. Consisting of live, focused, interactive educational sessions in a convenient 1-day format the conference provided:

The conference’s intimate audience size facilitated a higher level of interaction among participants and faculty. “It has been a significant privilege to be a speaker at the CMHC meetings. I have learned a great deal from the other faculty members and from the audiences' insightful questions and comments,” Lawrence Blonde, MD, who delivered presentations at both Chicago and Atlanta Best of the CMHC series said. Speaker Peter H. Jones, MD, said, “The smaller group size allows local/regional healthcare providers to have greater faculty contact, to have their questions answered after the lectures, and have time to connect with colleagues.”

  • updates on current, new, and emerging therapies
  • recommended guidelines
  • clinical strategies to individualize care and empower patients to reduce global cardiometabolic risk and improve clinical outcomes.

More than one-third of the US population has at least one cardiometabolic disorder such as diabetes, dyslipidemia, obesity, or hypertension, with an ever-increasing presence that continues to create major challenges for healthcare providers. Employing aggressive strategies for early identification and comprehensive management of patients presenting with multiple cardiometabolic risk factors is key to stemming the future burden of cardiovascular and metabolic disease. Visit the Cardiometabolic Health Congress website @cardiometabolichealth.org, for more information on CMHC live conferences, a free online CME-CE library, news, and clinician resources.

Press Room Archive